Início/Ações/PACB

PACB

USD

Pacific Biosciences of California Inc. Common Stock

$1.760+0.020 (1.149%)

Preço em tempo real

Healthcare

Dispositivos médicos

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$1.740

Máximo

$1.790

Mínimo

$1.630

Volume

10.33M

Fundamentos da empresa

Capitalização de mercado

531.4M

Setor

Dispositivos médicos

País

United States

Estatísticas de negociação

Volume médio

8.24M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $0.85Atual $1.760Máximo $2.66

Notícias relacionadas

10/11/2025 · 14:16

Analyst Upgrades

Stephens & Co. Maintains Overweight on Pacific Biosciences, Raises Price Target to $2

Stephens & Co. analyst Mason Carrico maintains Pacific Biosciences with a Overweight and raises the price target from $1.8 to $2.

Ver mais

Stephens & Co. Maintains Overweight on Pacific Biosciences, Raises Price Target to $2

4/11/2025 · 14:05

GlobeNewswire

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced that, through its long-standing partnership with Berry

Ver mais

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

22/10/2025 · 20:05

GlobeNewswire

PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5,

Ver mais